Integrative Research Training in Pediatric Cardiopulmonary Disease Fellowship
This T32 Fellowship Program is hosted by the Abigail Wexner Research Institute at Nationwide Children's Hospital and The Ohio State University, and is supported by the National Heart, Lung and Blood Institute (NIH/ NHLBI).
The overall goal of this program is to provide interdisciplinary, state-of-the-art research training in pediatric heart and lung diseases. Our program provides a unique integrated approach to prepare postdoctoral trainees to become scientists and physician-scientists who will make basic, translational, and clinical research discoveries through cooperative, collaborative team science. The rationale, for this holistic approach spanning molecular discovery, translational approaches using cell and animal models to human clinical trials, is that these synergistic methods will more rapidly impact patient care and therapies for infants and children with cardiopulmonary diseases. We will provide an academic environment that cultivates research training at a leading pediatric research institute affiliated with an internationally recognized children’s hospital and at The Ohio State University.
What You Need to Know
- MD, DO, MD/PhD, or postdoctoral trainees
- Strong interest in pediatric cardiopulmonary research and committed to careers in a disease-oriented investigation
- Candidate must be a citizen or a non-citizen national of the United States or have been lawfully admitted for permanent residence at the time of appointment
- Candidates with basic, translational, and/or clinical training are invited to apply
- Proposed research must be directly related to aspects of pediatric heart and lung diseases
- 1-year fellowship that is renewed based on productivity (for an additional year)
- Appointees are required to participate in the T32-developed curriculum (i.e., didactic coursework, seminars)
- Applicants are scored in 3 areas: trainee qualifications, scientific merit, and training potential.
Diversity and Inclusion
We are deeply committed to recruiting and retaining a diverse group of trainees and employees that reflects our patient population and community, with a focus on candidates who are Underrepresented in Medicine (URiM).
Those who are economically disadvantaged, disabled and/or part of a group or community that is Underrepresented in Medicine (URiM) are strongly encouraged to apply.
Deadline & Appointment
Applications will be due as early as June 18, 2023, but will be accepted on an ongoing basis if positions are available. As fellowship positions become available, applicants will be considered for support and notified of their selection by the Program Directors, Vidu Garg, MD and Carl Backes, MD.
Appointees will receive a stipend (at appropriate NIH stipend guidelines), benefits, and tuition support.
Fellowship appointments will begin as early as July 1, 2023.
- Application Cover Sheet
- Overview of proposed project (2 pages)
- Description of long-term career objectives (1 page)
- Applicant's NIH biosketch
- Letter of Support from prospective Mentor (max. 2 pages)
- Prospective Mentor's NIH Biosketch with relevant grant support
- One additional letter of reference (not from T32 sponsor) emailed directly to Program Coordinator, Emily Cameron.
Applications must be submitted electronically in a single PDF file to the Program Coordinator, Emily Cameron.
This fellowship program requires the applicant to choose a mentor during the application process. Please review our list of mentors from Nationwide Children's Hospital and The Ohio State University.
Vidu Garg, MD
Director, Center for Cardiovascular Research, Nationwide Children's Hospital
Professor of Pediatrics and Molecular Genetics, The Ohio State University
Carl Backes, MD
Director, Ohio Perinatal Research Network
Principal Investigator, Center for Perinatal Research, Nationwide Children's Hospital
Professor of Pediatrics, The Ohio State University
The Center for Cardiovascular Research conducts innovative research leading to improved therapies and outcomes for pediatric cardiovascular diseases and promotes cardiovascular health in adults.Learn More